News
11th October 2017
Tillotts Pharma: Positive Results of Largest Phase III Clinical Trial of Mesalazine Induction Therapy Published
more »
11th September 2017
A small fish in the big pond
more »
18th May 2017
Tillotts Pharma shows support for World IBD Day 2017
more »
25th April 2017
ECCO Satellite Symposium Report
more »
5th April 2017
Tillotts Pharma featured in Pharmaboardroom.com and Pharmaceutical Executive Magazine
more »
18th November 2016
Tillotts Pharma introduces OPTICORE™
more »
6th September 2016
Tillotts Pharma AG celebrates its 30th anniversary in Switzerland with the conference “Making Visions Happen”.
more »
6th September 2016
Tillotts Pharma opens in France and celebrates 30 Years anniversary.
more »
7th June 2016
Tillotts Pharma – 30 years of pioneering research in Switzerland
more »
9th June 2015
Tillotts Pharma AG under Agreement to Acquire Global Rights for Entocort® (budesonide) from AstraZeneca Outside the U.S.
more »
9th June 2015
Tillotts Pharma and Numab Announce Exclusive Development and Licensing Agreement
more »
1st May 2015
Tillotts Pharma supports the World IBD Day
more »
20th February 2015
Tillotts annouces results of European survey in ulcerative colitis
more »
9th January 2014
CPP, Inc. and Tillotts Pharma AG sign licensing agreement
more »
